Literature DB >> 13463098

Thyroxine-binding by serum and urine proteins in nephrosis; qualitative aspects.

J ROBBINS, J E RALL, M L PETERMANN.   

Abstract

Entities:  

Keywords:  BLOOD PROTEINS; NEPHROSIS/metabolism; PROTEINS/in urine; THYROXIN/metabolism

Mesh：

Substances：

Year:  1957        PMID： 13463098      PMCID： PMC1072731          DOI： 10.1172/JCI103532

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  15 in total

1.  Quantitative estimation of antigens by complement fixation; studies on the heat-labile alpha-2 glycoprotein.

Authors:  A PETERKOFSKY; L LEVINE; R K BROWN
Journal:  J Immunol       Date:  1956-03       Impact factor: 5.422

2.  Thyroxine metabolism in the nephrotic syndrome.

Authors:  H RASMUSSEN
Journal:  J Clin Invest       Date:  1956-07       Impact factor: 14.808

3.  Thyroglobulin in serum after I131 therapy. I. Salting out.

Authors:  J ROBBINS
Journal:  J Biol Chem       Date:  1954-05       Impact factor: 5.157

4.  Electrophoretic studies on fast moving components of human serum.

Authors:  H HOCH; A CHANUTIN
Journal:  J Biol Chem       Date:  1953-01       Impact factor: 5.157

5.  Zone electrophoresis in filter paper of serum I 131 after radioiodide administration.

Authors:  J ROBBINS; J E RALL
Journal:  Proc Soc Exp Biol Med       Date:  1952-11

6.  THE RELATION OF ALBUMIN TO PRECIPITABLE IODINE OF SERUM.

Authors:  J P Peters; E B Man
Journal:  J Clin Invest       Date:  1948-07       Impact factor: 14.808

7.  Observations on a rapidly migrating electrophoretic component of cerebrospinal fluid.

Authors:  A A FISK; A CHANUTIN; W O KLINGMAN
Journal:  Proc Soc Exp Biol Med       Date:  1951-10

8.  Nature of the circulating thyroid hormone-plasma protein complex.

Authors:  A H GORDON; J GROSS; D O'CONNOR; R PITT-RIVERS
Journal:  Nature       Date:  1952-01-05       Impact factor: 49.962

9.  Thyroid function in nephrosis.

Authors:  L RECANT; D S RIGGS
Journal:  J Clin Invest       Date:  1952-08       Impact factor: 14.808

10.  Localization of Protein-bound Radioactive Iodine by Filter Paper Electrophoresis.

Authors:  F Larson; W P Deiss; E C Albright
Journal:  Science       Date:  1952-06-06       Impact factor: 47.728
View more
  9 in total

1.  Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome.

Authors:  M T Collins; A T Remaley; G Csako; F Pucino; M C Skarulis; J E Balow; N J Sarlis
Journal:  J Endocrinol Invest       Date:  2000-06       Impact factor: 4.256

Review 2.  [ON THE DETERMINATION OF INORGANIC IODINE IN HUMAN SERUM].

Authors:  W FITTING
Journal:  Klin Wochenschr       Date:  1964-08-01

3.  Experience with an in vitro test of thyroid function--the red blood cell uptake of L-triiodothyronine labelled with radioactive iodine.

Authors:  P G WALFISH; A BRITTON; R VOLPE; C EZRIN
Journal:  Can Med Assoc J       Date:  1961-03-25       Impact factor: 8.262

4.  Thyroxine displacement from serum proteins and depression of serum protein-bound iodine by certain drugs.

Authors:  J WOLFF; M E STANDAERT; J E RALL
Journal:  J Clin Invest       Date:  1961-08       Impact factor: 14.808

5.  The effect of estrogens upon the peripheral metabolism of thyroxine.

Authors:  J T DOWLING; N FREINKEL; S H INGBAR
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

6.  Thyroxine binding by serum proteins.

Authors:  W E BALFOUR; H E TUNNICLIFFE
Journal:  J Physiol       Date:  1960-08       Impact factor: 5.182

7.  Thyroxinebinding by serum protein in pregnancy and in the newborn.

Authors:  J ROBBINS; J H NELSON
Journal:  J Clin Invest       Date:  1958-02       Impact factor: 14.808

8.  The interpretation of the serum protein-bound iodine: A review.

Authors:  J D Acland
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

9.  Hypothyroidism in infants with nephrotic syndrome.

Authors:  T K Mattoo
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.